Drug Profile
Carbetocin - Travere Therapeutics
Alternative Names: CYP-2001Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Nastech Pharmaceutical Company
- Developer Retrophin
- Class Antihaemorrhagics; Oxytocics; Posterior pituitary hormones
- Mechanism of Action Oxytocin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Autistic disorder